|
|
|
| |
|
|
| |
The latest infectious diseases news from News Medical |
|
|
|
 | | |
[Free eBook] Advancing infectious disease vaccine development
In Infectious disease research, early-phase development is moving fast. To keep up, leading teams are rethinking how they work, from improving sample stabilization and enabling outpatient models to generating high-quality, regulatory-ready data from day one.
| |
|
|
|  | | | | | US measles and pertussis outbreaks expose policy failures, not just vaccine hesitancy A recent commentary argues that US measles and pertussis outbreaks are not simply the result of vaccine hesitancy but reflect weakened immunization policies, permissive exemptions, and underfunded public health systems. The authors contend that policy environments determine whether pockets of low coverage escalate into large-scale, preventable outbreaks. | |  | | | | | New antimicrobial strategies show how science is tackling rising drug resistance This narrative review in the British Journal of Biomedical Science examines emerging and recently approved therapeutic strategies to combat antimicrobial resistance, spanning new antibiotics, microbiome interventions, natural products, predatory bacteria, vaccines, and advanced technologies. It highlights both promising innovations and the urgent need for sustained global investment as many approaches remain in early development. | |
|
|
|  | | | A recent study, published in Nature Communications, shows that in the Netherlands, people who are diagnosed with HIV are less likely to be employed, work fewer hours, earn less income, and are more likely to receive disability benefits up to seven years after diagnosis. | | | | | A new multinational study from the INTERCOVID Consortium, including Ann & Robert H. Lurie Children's Hospital of Chicago, has found that COVID-19 vaccination during pregnancy, particularly when combined with a booster dose, significantly reduces the risk of preeclampsia, a serious and potentially life-threatening pregnancy complication. | | | | | Booster vaccines reduced the risk of COVID‑19–related hospitalisation and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England. | | | | | SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression. | | | | | Even a mild case of COVID-19 or the flu can impact the body long after the fever and cough fade, according to new Tulane University research that may help explain why some people struggle to feel fully recovered weeks or months later. | | | | | Researchers at Kumamoto University have discovered that behavioral changes during the COVID-19 pandemic-particularly widespread mask-wearing-may have reduced the risk of certain types of heart attacks triggered by air pollution. | | | | | A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), may be able to effectively replace more complicated HIV treatment regimens used by people living with HIV who are long-term survivors, according to the results of a new phase 3 clinical trial published in The Lancet. | |
|
|
|  | | | How would you rate today's newsletter?
| |
|
|
|  | | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|
|
|
|